Furthermore, the potential of NLR as a predictor of prostate cancer diagnosis has been evaluated in patients with significant clinical characteristics of prostate cancer and prostate-specific antigen (PSA) levels less than 10 ng/ml. The gene discussed is KLK3; the disease is prostate carcinoma.